Trial: 201901009

A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma

Phase

I/II

Principal Investigator

Huang, Jiayi

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov